Related Experiment Video
Updated: Feb 6, 2026

The Supraclavicular Fossa Ultrasound View for Central Venous Catheter Placement and Catheter Change Over Guidewire
Published on: December 23, 2014
SecurAcath for Securing Peripherally Inserted Central Catheters: A NICE Medical Technology Guidance
Tom Macmillan1, Mark Pennington2, Jennifer A Summers3
1King's Technology Evaluation Centre, School of Biomedical Engineering and Imaging Sciences, King's College London, 5th Floor, Becket House, 1 Lambeth Palace Road, London, SE1 7EU, UK. thomas.macmillan@kcl.ac.uk.
SecurAcath offers a securement solution for central venous catheters. While StatLock may be more cost-effective for short-term use, SecurAcath proves more economical for medium- and long-term catheter indwell times.
Area of Science:
- Medical Devices
- Health Technology Assessment
- Clinical Engineering
Background:
- Central venous catheters (CVCs) are crucial for patient therapy and monitoring.
- Effective securement of CVCs is essential to prevent dislodgement.
- SecurAcath is a novel device for CVC securement.
Purpose of the Study:
- To evaluate the clinical and economic evidence for the SecurAcath device.
- To compare SecurAcath against alternative catheter securement methods.
- To inform National Institute for Health and Care Excellence (NICE) guidance on CVC securement.
Main Methods:
- Systematic review and meta-analysis of existing evidence.
- Independent critique of manufacturer-submitted clinical and economic data.
- Development and revision of a cost-effectiveness economic model.
Main Results:
- Limited comparative evidence initially identified; one unpublished RCT showed potential non-inferiority to StatLock.
- Revised economic model indicated StatLock is more cost-effective for ≤5-day indwell times.
- SecurAcath demonstrated greater cost-effectiveness for medium- and long-term catheter use.
Conclusions:
- SecurAcath shows potential non-inferiority to StatLock for CVC securement.
- Cost-effectiveness varies by catheter indwell duration.
- NICE recommended SecurAcath adoption for specific CVC applications in the NHS.
Related Concept Videos
Peripherally and Centrally Acting Muscle Relaxants: A Comparison
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
The Central Dogma
The Central Dogma
RNA is the Missing Link Between DNA and Proteins
In the early 1900s, scientists discovered that DNA stores all the information needed for cellular functions and that proteins perform most of these functions. However, the mechanisms of converting genetic information into functional proteins remained unknown for many years. Initially, it was believed that a single gene is...
Measures of Central Tendency
Inhaled Medications
Hybridoma Technology
Hybridoma Selection
Commonly used fusion techniques — electroporation,...

